LFST logo

LifeStance Health (LFST)

Profile

Full Name

LifeStance Health Group, Inc.

Ticker Symbol

LFST

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Care Facilities

Country

United States

IPO

June 10, 2021

Indexes

Not included

Website

http://lifestance.com

Employees

10218

Key Details

Price

$6.71(-1.61%)

Market cap

$2.58B(Mid cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$1.25B(+18.50% YoY)

Annual EPS

-$0.15(+70.59% YoY)

PE ratio

-

Next earnings date

May 9, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$6.71
LFST price is $6.71

30-Day Relative Volume

0.40
LFST 30-day relative volume is 0.40

Price Performance

Price Most recent change

-1.61%
LFST price was down -1.61% on Apr 16, 2025

Price YTD change

-8.96%
LFST price is down -8.96% since January 1st

Price 1-year change

+17.93%
LFST price is up +17.93% year-on-year

Price 3-year change

-38.94%
LFST price is down -38.94% over the past 3 years

Price Range

Price All-time high

$29.81
LFST price is currently -77.49% below its historical high of $29.81

Price 3-year low

$4.22
LFST price is currently +59.00% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$2.58B
LFST market capitalization is $2.58 billion

Market cap 3-year change

-37.28%
LFST market capitalization is down -37.28% over the past 3 years

Market cap All-time high

$10.83B
LFST market capitalization is currently -76.18% below its historical high of $10.83 billion

Market cap sector rank

85.12%
LFST market capitalization is higher than 85.12% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.6%
LFST shares outstanding is up +0.6% year-on-year

Shares Outstanding 3-Year Change

+2.73%
LFST shares outstanding is up +2.73% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.62
LFST beta is 0.62

200-day SMA

$6.90
LFST price is currently -2.80% below its 200-day simple moving average

50-day SMA

$7.26
LFST price is currently -7.56% below its 50-day simple moving average

RSI

43.22
LFST 14-day relative strength index is 43.22

Volume

0.40
LFST 30-day relative volume is 0.40

ATR

$0.27
LFST average true range is $0.27

10-day Historical Volatility

37.62%
LFST 10-day historical volatility is 37.62%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$1.25B
LFST annual revenue is $1.25 billion

Revenue Analysts estimate

$1.42B
LFST annual revenue is currently -11.70% lower than the consensus analysts' forecast

Revenue 1-year change

+18.5%
LFST annual revenue is up +18.5% year-on-year

Revenue Sector rank

82.19%
LFST annual revenue is higher than 82.19% of companies in Healthcare sector

EPS

EPS

-$0.15
LFST annual earnings per share is -$0.15

EPS Analysts estimate

$0.06
LFST annual earnings per share is currently -353.81% lower than the consensus analysts' forecast

EPS 1-year change

+70.59%
LFST annual earnings per share is up +70.59% year-on-year

EPS Sector rank

79.17%
LFST annual earnings per share is higher than 79.17% of companies in Healthcare sector

Profit

Gross profit

$402.40M
LFST annual gross profit is $402.40 million

Gross margin

32.17%
LFST annual gross profit margin is 32.17%

Operating profit

-$31.61M
LFST annual operating income is -$31.61 million

Operating margin

-2.53%
LFST annual operating profit margin is -2.53%

Net income

-$57.44M
LFST annual net profit is -$57.44 million

Net margin

-4.59%
LFST annual net profit margin is -4.59%

Expenses

Total expenses

$1.28B
LFST annual total expenses is $1.28 billion

Operating expenses

$434.01M
LFST annual total operating expenses is $434.01 million

Cost of goods sold

$848.57M
LFST annual cost of goods sold is $848.57 million

Selling, general & administrative expenses

$363.06M
LFST annual SGA is $363.06 million

Depreciation and amortization

$70.95M
LFST annual depreciation & amortization is $70.95 million

Interest expense

$26.54M
LFST annual interest expense is $26.54 million

Income tax

-$170.00K
LFST annual income tax is -$170.00 thousand

EBIT & EBITDA

EBIT

-$31.08M
LFST annual earnings before interest & taxes is -$31.08 million

EBITDA

$39.87M
LFST annual EBITDA is $39.87 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$2.12B
LFST annual total assets is $2.12 billion

Non current assets

$1.81B
LFST annual long term assets is $1.81 billion

Current assets

$312.51M
LFST annual total current assets is $312.51 million

Cash and cash equivalents

$154.57M
LFST annual cash & cash equivalents is $154.57 million

Accounts receivable

$131.80M
LFST annual accounts receivable is $131.80 million

Inventory

-
LFST annual inventory value is unknown

Liabilities

Total liabilities

$672.01M
LFST annual total liabilities is $672.01 million

Long term liabilities

$443.13M
LFST annual total long term liabilities is $443.13 million

Current liabilities

$228.89M
LFST annual total current liabilities is $228.89 million

Accounts payable

$25.68M
LFST annual accounts payable is $25.68 million

Debt

Total debt

$485.19M
LFST annual total debt is $485.19 million

Total debt 1-year change

-5.06%
LFST annual total debt is down -5.06% year-on-year

Long term debt

$428.49M
LFST annual long term debt is $428.49 million

Short term debt

$56.70M
LFST annual short term debt is $56.70 million

Equity & Capital

Shareholders equity

$1.45B
LFST annual stockholders equity is $1.45 billion

Book value

$1.45B
LFST annual book value is $1.45 billion

Retained earnings

-$818.29M
LFST annual retained earnings is -$818.29 million

Working capital

$83.62M
LFST annual working capital is $83.62 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$107.26M
LFST annual cash flow from operations is $107.26 million

Cash from operations 1-year change

+735.28%
LFST annual cash flow from operations is up +735.28% year-on-year

Cash from investing

-$21.57M
LFST annual cash flow from investing activities is -$21.57 million

Cash from investing 1-year change

+64.26%
LFST annual cash flow from investing activities is up +64.26% year-on-year

Cash from financing

-$9.95M
LFST annual cash flow from financing activities is -$9.95 million

Cash from financing 1-year change

-120.97%
LFST annual cash flow from financing activities is down -120.97% year-on-year

CAPEX

CAPEX

$21.57M
LFST annual capital expenditures is $21.57 million

CAPEX 1-year change

-46.78%
LFST annual capital expenditures is down -46.78% year-on-year

Free Cash Flow

Free cash flow

$85.69M
LFST annual free cash flow is $85.69 million

Free cash flow 1-year change

+249.28%
LFST annual free cash flow is up +249.28% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

32.17%
LFST annual gross profit margin is 32.17%

Operating margin

-2.53%
LFST annual operating profit margin is -2.53%

Net margin

-4.59%
LFST annual net profit margin is -4.59%

ROA & ROE

ROA

-2.72%
LFST annual return on assets is -2.72%

ROE

-4.00%
LFST annual return on equity is -4.00%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
LFST price to earnings ratio value is unknown

PE ratio Sector rank

-
LFST price to earnings ratio is unknown

PB Ratio

PB ratio

1.78
LFST price to book ratio is 1.78

PB ratio Sector rank

60.05%
LFST price to book ratio is higher than 60.05% of companies in Healthcare sector

PS Ratio

PS ratio

2.06
LFST price to sales ratio is 2.06

PS ratio Sector rank

43.85%
LFST price to sales ratio is higher than 43.85% of companies in Healthcare sector

Enterprise value

Enterprise value

$2.91B
LFST enterprise value is $2.91 billion

Enterprise value Sector rank

85.22%
LFST enterprise value is higher than 85.22% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

73.01
LFST EV/EBITDA is 73.01

EV/EBITDA Sector rank

98.26%
LFST EV/EBITDA is higher than 98.26% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.37
LFST annual current ratio is 1.37

Quick ratio

-
LFST annual quick ratio value is unknown

Leverage

Debt to equity

0.20
LFST annual debt to equity ratio is 0.20

Interest coverage ratio

-1.17
LFST annual interest coverage ratio is -1.17

Risk & Stability

Piotroski F-Score

6
LFST piotroski f-score is 6

Altman Z-Score

2.35
LFST altman z-score is 2.35

Analyst ratings

Recent major analysts updates

Apr 8, 25 Keybanc
Overweight
Apr 3, 25 Canaccord Genuity
Buy
Dec 16, 24 Goldman Sachs
Buy
Nov 11, 24 Barclays
Underweight
Aug 15, 24 UBS
Neutral
Aug 9, 24 Barclays
Underweight
Apr 22, 24 Morgan Stanley
Overweight
Mar 6, 24 Jefferies
Buy
Mar 4, 24 Goldman Sachs
Neutral
Feb 29, 24 Barclays
Underweight

Institutional Ownership

Similar stocks

XENE logo
Xenon Pharmaceuticals (XENE)
NVST logo
Envista Holdings (NVST)
Concentra Group Holdings Parent (CON)
IMVT logo
Immunovant (IMVT)
XRAY logo
DENTSPLY SIRONA (XRAY)
VKTX logo
Viking Therapeutics (VKTX)
ALVO logo
Alvotech (ALVO)
SGRY logo
Surgery Partners (SGRY)
VCYT logo
Veracyte (VCYT)
  • What is the ticker symbol for LifeStance Health?
  • Does LifeStance Health pay dividends?
  • What sector is LifeStance Health in?
  • What industry is LifeStance Health in?
  • What country is LifeStance Health based in?
  • When did LifeStance Health go public?
  • Is LifeStance Health in the S&P 500?
  • Is LifeStance Health in the NASDAQ 100?
  • Is LifeStance Health in the Dow Jones?
  • When was LifeStance Health's last earnings report?
  • When does LifeStance Health report earnings?
  • Should I buy LifeStance Health stock now?

What is the ticker symbol for LifeStance Health?

The ticker symbol for LifeStance Health is NASDAQ:LFST

Does LifeStance Health pay dividends?

No, LifeStance Health does not pay dividends

What sector is LifeStance Health in?

LifeStance Health is in the Healthcare sector

What industry is LifeStance Health in?

LifeStance Health is in the Medical Care Facilities industry

What country is LifeStance Health based in?

LifeStance Health is headquartered in United States

When did LifeStance Health go public?

LifeStance Health's initial public offering (IPO) was on June 10, 2021

Is LifeStance Health in the S&P 500?

No, LifeStance Health is not included in the S&P 500 index

Is LifeStance Health in the NASDAQ 100?

No, LifeStance Health is not included in the NASDAQ 100 index

Is LifeStance Health in the Dow Jones?

No, LifeStance Health is not included in the Dow Jones index

When was LifeStance Health's last earnings report?

LifeStance Health's most recent earnings report was on Feb 27, 2025

When does LifeStance Health report earnings?

The next expected earnings date for LifeStance Health is May 9, 2025

Should I buy LifeStance Health stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page